AT

attivare

3 known investors

attivaretx.com ↗

Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.

Investors · 3

UL

Ulu VenturesPalo Alto · $2M

AX

Axial VCreportedSan Francisco · $100K – $5M

EM

Embark VenturesreportedLos Angeles